EUVIMEDEUVIMED entdecken
Leitlinie

Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology

Daniel A Pollyea, Jessica K Altman, Rita Assi, Dale Bixby, Amir T Fathi, James M Foran, Ivana Gojo, Aric C Hall, Brian A Jonas, Ashwin Kishtagari, Jeffrey Lancet, Lori Maness und 25 weitere

Journal of the National Comprehensive Cancer Network · 2023-05 · 21 (5) · 503-513

DOI: 10.6004/jnccn.2023.0025 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of the National Comprehensive Cancer Network, 2023-05. Verfasst von Daniel A Pollyea und 36 weiteren Autor:innen. Beteiligte Einrichtung: University of Colorado Cancer Center. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Leukemia, Myeloid, Acute, Skin Neoplasms. Die Arbeit wurde bisher 191-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy characterized by the clonal expansion of myeloid blasts in the peripheral blood, bone marrow, and/or other tissues. It is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths from leukemias in the United States. Like AML, blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a myeloid malignancy. It is a rare malignancy characterized by the aggressive proliferation of precursors of plasmacytoid dendritic cells that frequently involves the bone marrow, skin, central nervous system, and other organs and tissues. This discussion section focuses on the diagnosis and management of BPDCN as outlined in the NCCN Guidelines for AML.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsLeukemia, Myeloid, AcuteSkin NeoplasmsAdultHumansDendritic CellsMedical Oncology

Autor:innen und Institutionen

  • University of Colorado Cancer Center.
  • Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center.
  • University of Michigan Rogel Cancer Center.
  • Massachusetts General Hospital Cancer Center.
  • Mayo Clinic Comprehensive Cancer Center.

Förderung

  • NCI NIH HHS

Zitieren

APA

Pollyea, D. A., Altman, J. K., Assi, R., Bixby, D., Fathi, A. T., Foran, J. M., Gojo, I., Hall, A. C., Jonas, B. A., Kishtagari, A., Lancet, J., Maness, L., Mangan, J., Mannis, G., Marcucci, G., Mims, A., Moriarty, K., Mustafa Ali, M., Neff, J., …, & Stehman, K. (2023). Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 21(5), 503-513. https://doi.org/10.6004/jnccn.2023.0025

Vancouver

Pollyea DA, Altman JK, Assi R, Bixby D, Fathi AT, Foran JM, et al. Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2023;21(5):503-513. doi:10.6004/jnccn.2023.0025

BibTeX
@article{Pollyea2023,
  author = {Pollyea, Daniel A and Altman, Jessica K and Assi, Rita and Bixby, Dale and Fathi, Amir T and Foran, James M and Gojo, Ivana and Hall, Aric C and Jonas, Brian A and Kishtagari, Ashwin and Lancet, Jeffrey and Maness, Lori and Mangan, James and Mannis, Gabriel and Marcucci, Guido and Mims, Alice and Moriarty, Kelsey and Mustafa Ali, Moaath and Neff, Jadee and Nejati, Reza and Olin, Rebecca and Percival, Mary-Elizabeth and Perl, Alexander and Przespolewski, Amanda and Rao, Dinesh and Ravandi, Farhad and Shallis, Rory and Shami, Paul J and Stein, Eytan and Stone, Richard M and Sweet, Kendra and Thota, Swapna and Uy, Geoffrey and Vachhani, Pankit and Cassara, Carly J and Freedman-Cass, Deborah A and Stehman, Katie},
  title = {Acute Myeloid Leukemia, Version 3.2023, NCCN Clinical Practice Guidelines in Oncology},
  journal = {Journal of the National Comprehensive Cancer Network},
  year = {2023},
  volume = {21},
  number = {5},
  pages = {503--513},
  doi = {10.6004/jnccn.2023.0025}
}
Kostenlos starten →